More and more biotech and pharmaceutical companies including big names like Eli Lily, AstraZeneca, Janssen, Charles River and Bayer are investing in AI and machine learning for drug discovery. But there are those who say we need to be cautious when using these approaches for synthesising complex molecules.

And yes, I got Enamine’s name wrong, apparently I can’t read. Sorry!

Follow me on:

Youtube: youtube.com/haveyoueverwondered

Content by Maaria Ginai (C) 2019